Friday, December 11, 2020 10:37:19 AM
Hello !! Anyone home? Anybody following this stock?
Recent ILMN News
- DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows • PR Newswire (US) • 04/16/2026 01:15:00 PM
- Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease • PR Newswire (US) • 04/14/2026 01:15:00 PM
- Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 • PR Newswire (US) • 04/09/2026 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:21:21 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:18:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:16:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:32:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:09:56 PM
- Illumina Announces Changes to Board of Directors • PR Newswire (US) • 04/02/2026 01:07:00 PM
- Illumina and Labcorp expand collaboration to broaden access to precision oncology testing • PR Newswire (US) • 03/18/2026 01:15:00 PM
- Illumina advances preventive genomics through strategic consortium with Veritas Genetics • PR Newswire (US) • 03/16/2026 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:06:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:59:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:56:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:55:02 PM
- Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering • PR Newswire (US) • 03/05/2026 02:15:00 PM
- Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida • PR Newswire (US) • 02/27/2026 02:15:00 PM
- Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics • PR Newswire (US) • 02/25/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 09:11:26 PM
- Illumina launches TruPath Genome, setting a new standard in genomic insight • PR Newswire (US) • 02/24/2026 05:15:00 PM
- Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility • PR Newswire (US) • 02/23/2026 02:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 09:28:03 PM
